NEW YORK (360Dx) – Spanish diagnostics firm Biohope is about to commence a large-scale study of its flagship Immunobiogram in vitro diagnostic for determining the best immunosuppressive treatment for patients undergoing kidney transplantation.

The €3.8 million ($4.5 million) project, called Transbio, has been funded through the EU's Horizon 2020 program and will run through 2019. Biohope recently completed a pilot phase of the two-year study in partnership with two Spanish hospitals that yielded positive results.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.